Delivering value
to healthcare systems
and patients.

The Metadvice platform has a positive impact on the management of chronic long term conditions where management is particularly complex. We take knowledge from approved guidelines and refine it based on patient cohort and digital twin data in order to provide actionable insights and clinical decisions, enabling real precision medicine.

Cardiometabolic disease

Phase 1 of tackling chronic long-term conditions

Metadvice is focused on improving the effectiveness and efficiency of care for people with multiple long-term conditions, with an initial emphasis on cardiometabolic disease. Cardiometabolic disease includes conditions such as hyper­cholesterolaemia, hypertension and type 2 diabetes, where growing numbers of high-risk patients are placing a burden on global health systems, and for which better diagnostic and treatment approaches are needed.

Moving into Phase 2 of tackling chronic long-term conditions

By the end of 2024, we aim to cover the majority of chronic conditions that occur at the primary care stage, as we work towards the future of healthcare.

Questions? Get in touch.

If you would like to discuss collaboration opportunities, please contact us.